Linked Life Data

19896351

Source:http://linkedlifedata.com/resource/pubmed/id/19896351

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2009-11-30
pubmed:abstractText
Immunosuppressants, including methotrexate and more recently anti-TNF alpha, anti-IL1 and anti-IL6 receptor, have modified the prognosis of juvenile idiopathic arthritis. Growth hormone was shown to limit growth retardation due to general corticotherapy.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1769-664X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1607-11
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
[New treatments for idiopathic juvenile arthritis].
pubmed:affiliation
Service d'Immunologie, d'Hématologie et de Rhumatologie Pédiatriques, Centre de Référence << Arthrites Juvéniles >>, Université Paris Descartes, Hôpital Necker-Enfants-Malades, 149 Rue de Sèvres, 75015 Paris, France. brigitte.bader-meunier@nck.aphp.fr
pubmed:publicationType
Journal Article, English Abstract